We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.74% | 17.75 | 17.00 | 18.50 | 18.25 | 17.75 | 18.25 | 90,680 | 08:49:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.0666 | -2.67 | 8M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/5/2024 17:17 | LR2 you had some questions and made assertions about Nimble in the other place. This below should help you with your worries: "Imaging Biometrics, LLC data security statement (2024-05-28): Imaging Biometrics (IB) and its developed software applications (apps) comply with the requirements of the US HIPAA and the EU GDPR regulations. IB applies the principles outlined in the US FDA cybersecurity guidance to all the software apps it develops, whether or not a given app is technically classified as a medical device. IB is evaluating the changes in the newly-released revision 3 of the US NIST share price 800-171r3 standard for integration into its policies, procedures, and software development process. Similarly, IB is pursuing implementation of the recommendations contained in the NIST share price 800-218 secure software development framework and ISO 27001 information security standards. Note IB does not host the data accessed via IB Nimble. All data is hosted by the implementing client institution within its data center and is also subject to the institution’s privacy and information security policies and practices." You're welcome! Perhaps you share with the LSE posters you engaged with recently? You were commenting upon this RNS: | ydderf | |
24/5/2024 17:03 | I guess the delayed trade might be the reason for the rise today. 23-May-24 13:12:51 63.00 79,821 Unknown* 65.00 72.00 50.29k | lr2 | |
23/5/2024 08:26 | Even Sunak is talking about CDC’s ! He’s a politician though, so sounding positive about something that will take years to do on any scale is ok. Not so if you run a business. | yump | |
22/5/2024 08:34 | More in depth analysis I presume from the resident expert. Hopefully by now everyone has these odd uninvolved people on filter although I guess they think folk are hanging on their every word, which is pretty sad really. | yump | |
22/5/2024 07:08 | I see one of the RNS chasing pointless posters has turned up with presumably some sort of one-liner. | yump | |
22/5/2024 06:10 | Well that reads well this morning. “Optimise cost base” by getting shot of TO asap. | ducatiman | |
17/5/2024 14:02 | Or Positive QVH news followed by other NHS contracts and it’s fireworks. 20p or £20. | ducatiman | |
17/5/2024 11:34 | Grand old Duke of York job. Any value left? Could be like magnet fishing - Pull up an unexploded grenade and all goes to money heaven. . | pugugly | |
16/5/2024 12:21 | They were going to reply after speaking to Fdbk. That tells you all you need to know. | ducatiman | |
16/5/2024 12:20 | Must be putting a lot of thought into their reply. | lr2 | |
16/5/2024 11:22 | I asked them a question a few years back, still awaiting the promised reply. | ducatiman | |
16/5/2024 09:56 | It was years ago but I got a response. I pointed out some grammar error on the website and they thanked me. | lr2 | |
16/5/2024 09:50 | Waste of time Yump, like most things associated with this bunch of numpties. | ducatiman | |
16/5/2024 08:15 | Has anyone ever had a reply from the investors contact form. I see it probably goes to walbrook PR. | yump | |
15/5/2024 07:42 | I wonder what TO will get his bonus for achieving this year? | ducatiman | |
13/5/2024 16:42 | “Some people are on the pitch”. | ducatiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions